PNEUMOCOCCAL TRANSFORMATION AND VIRULENCE

肺炎球菌转化和毒力

基本信息

  • 批准号:
    2072738
  • 负责人:
  • 金额:
    $ 16.14万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1994
  • 资助国家:
    美国
  • 起止时间:
    1994-08-01 至 1999-04-30
  • 项目状态:
    已结题

项目摘要

Streptococcus pneumoniae is a widespread pathogen and a leading cause of pneumonia, otitis media, bacteremia and meningitis. Since the current multivalent polysaccharide vaccines fail to protect those most susceptible to infection (children under the age of 2 and older adults), identification of proteins important to pneumococcal virulence is currently a high priority for new vaccine initiatives. The emergence and global spread of penicillin resistant pneumococci has also focused interest on horizontal gene transfer by natural transformation. We have recently reported the first use of random translational gene fusions (PhoA mutagenesis) to identify and alter exported proteins in a gram positive organism. We have also developed random transcriptional fusions (LacZ mutagenesis) to assess gene regulation in pneumococcus. Using this new technology, we have characterized several genetic loci with sequence similarity to known families of exported proteins. Homologs were found to protein-dependent peptide permeases, penicillin binding proteins, Clp proteases, two- component sensor regulators and ABC (ATP binding cassette) transporters responsible for the export of the RTX class of bacterial toxins. This technology makes it possible for the first time to map the surface proteins of the pneumococcus in a systematic and complete manner. Given the wealth of new proteins identified by our new gene fusion technology, we choose to focus this project on the identification and characterization of those surface proteins which are: 1] virulence determinants and thus could serve as candidates for a conjugate vaccine and 2] participants in the process of transformation by exogenous DNA. To do so, we will assess our banks of mutants for a loss of function in the steps of pneumococcal infection, particularly adherence to epithelia and endothelia and in the process of transformation. Based on preliminary work, mutations in 5 loci decrease pneumococcal adhesion by about 60% to Type II lung cells or endothelial cells. We will determine by genetic and molecular analysis if these loci directly encode adhesions or if they mediate expression as part of a regulatory cascade. The impact of these loci on virulence will be assessed in animal models for colonization and infection. Surface proteins that participate in adherence or other steps in pathogenesis will be assessed for immunogenic and protective activity with the aim of identifying new protein vaccine candidates. In further preliminary work, two distinct mutations decrease the efficiency of natural transformation by about 90. These loci are plpA which encodes a peptide permease and rec which is an operon that encodes an exported protein and a RecA homolog. We will test the hypothesis that plpA is a regulatory locus modulating transformation by transporting small oligopeptides that serve as intracellular messengers. The rec operon, is upregulated during transformation and is the first transformation-regulated gene to be cloned. We will identify both cis and trans acting elements that regulate expression of this locus in order to begin to assemble a model of the signaling cascade that controls the process of transformation.
肺炎链球菌是一种广泛存在的病原体,也是导致肺炎的主要原因

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

H ROBERT MASURE其他文献

H ROBERT MASURE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('H ROBERT MASURE', 18)}}的其他基金

PNEUMOCOCCAL TRANSFORMATION AND VIRULENCE
肺炎球菌转化和毒力
  • 批准号:
    2072737
  • 财政年份:
    1994
  • 资助金额:
    $ 16.14万
  • 项目类别:
PNEUMOCOCCAL TRANSFORMATION AND VIRULENCE
肺炎球菌转化和毒力
  • 批准号:
    2072740
  • 财政年份:
    1994
  • 资助金额:
    $ 16.14万
  • 项目类别:
PNEUMOCOCCAL TRANSFORMATION AND VIRULENCE
肺炎球菌转化和毒力
  • 批准号:
    2072739
  • 财政年份:
    1994
  • 资助金额:
    $ 16.14万
  • 项目类别:
PNEUMOCOCCAL TRANSFORMATION AND VIRULENCE
肺炎球菌转化和毒力
  • 批准号:
    2413689
  • 财政年份:
    1994
  • 资助金额:
    $ 16.14万
  • 项目类别:
ADENYLATE CYCLASE TOXIN FROM BORDETELLA PERTUSSIS
百日咳博德特氏菌腺苷酸环化酶毒素
  • 批准号:
    3456001
  • 财政年份:
    1991
  • 资助金额:
    $ 16.14万
  • 项目类别:
ADENYLATE CYCLASE TOXIN FROM BORDETELLA PERTUSSIS
百日咳博德特氏菌腺苷酸环化酶毒素
  • 批准号:
    2066923
  • 财政年份:
    1991
  • 资助金额:
    $ 16.14万
  • 项目类别:
ADENYLATE CYCLASE TOXIN FROM BORDETELLA PERTUSSIS
百日咳博德特氏菌腺苷酸环化酶毒素
  • 批准号:
    2066924
  • 财政年份:
    1991
  • 资助金额:
    $ 16.14万
  • 项目类别:
ADENYLATE CYCLASE TOXIN FROM BORDETELLA PERTUSSIS
百日咳博德特氏菌腺苷酸环化酶毒素
  • 批准号:
    2066922
  • 财政年份:
    1991
  • 资助金额:
    $ 16.14万
  • 项目类别:
ADENYLATE CYCLASE TOXIN FROM BORDETELLA PERTUSSIS
百日咳博德特氏菌腺苷酸环化酶毒素
  • 批准号:
    3456002
  • 财政年份:
    1991
  • 资助金额:
    $ 16.14万
  • 项目类别:
CHARACTERIZATION OF P-57; A CALMODULIN BINDING PROTEIN
P-57 的特性;
  • 批准号:
    3054422
  • 财政年份:
    1987
  • 资助金额:
    $ 16.14万
  • 项目类别:

相似海外基金

Identifying the correlates of protection against Streptococcus pneumoniae respiratory tract infection using a human challenge model
使用人体挑战模型确定预防肺炎链球菌呼吸道感染的相关性
  • 批准号:
    MR/Z503721/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.14万
  • 项目类别:
    Research Grant
The impact of thermally-regulated cell wall modifications on Streptococcus pneumoniae pathogenesis
热调节细胞壁修饰对肺炎链球菌发病机制的影响
  • 批准号:
    MR/X009130/1
  • 财政年份:
    2023
  • 资助金额:
    $ 16.14万
  • 项目类别:
    Research Grant
Cardiomyocyte self-defense against Streptococcus pneumoniae
心肌细胞对抗肺炎链球菌的自我防御
  • 批准号:
    10639102
  • 财政年份:
    2023
  • 资助金额:
    $ 16.14万
  • 项目类别:
Understanding how penicillin resistance develops in Streptococcus pneumoniae clinical populations
了解肺炎链球菌临床人群中青霉素耐药性如何发展
  • 批准号:
    2902003
  • 财政年份:
    2023
  • 资助金额:
    $ 16.14万
  • 项目类别:
    Studentship
ISS: Exploiting the Space Environment to Dissect the Molecular Basis of Streptococcus pneumoniae (Spn) Cardiotoxicity”
国际空间站:利用太空环境剖析肺炎链球菌 (Spn) 心脏毒性的分子基础 —
  • 批准号:
    2223072
  • 财政年份:
    2023
  • 资助金额:
    $ 16.14万
  • 项目类别:
    Standard Grant
Small RNA based control of zinc homeostasis in Streptococcus pneumoniae
基于小RNA的肺炎链球菌锌稳态控制
  • 批准号:
    10625448
  • 财政年份:
    2022
  • 资助金额:
    $ 16.14万
  • 项目类别:
Evolvable essentiality in the pan-genome of Streptococcus pneumoniae and its mechanistic and evolutionary consequences
肺炎链球菌全基因组的进化本质及其机制和进化后果
  • 批准号:
    10503286
  • 财政年份:
    2022
  • 资助金额:
    $ 16.14万
  • 项目类别:
THE IMPACT OF ADVANCED AGE AND SEX ON HUMORAL IMMUNITY TO STREPTOCOCCUS PNEUMONIAE
高龄和性别对肺炎链球菌体液免疫的影响
  • 批准号:
    10532071
  • 财政年份:
    2022
  • 资助金额:
    $ 16.14万
  • 项目类别:
TNF impairs macrophage killing of Streptococcus pneumoniae
TNF 损害巨噬细胞对肺炎链球菌的杀伤作用
  • 批准号:
    475472
  • 财政年份:
    2022
  • 资助金额:
    $ 16.14万
  • 项目类别:
    Studentship Programs
Utilization of the adjuvant effect of CRM197 protein to develop a trivalent protein-vaccine against Streptococcus pneumoniae infections
利用CRM197蛋白的佐剂作用开发抗肺炎链球菌感染的三价蛋白疫苗
  • 批准号:
    10552114
  • 财政年份:
    2022
  • 资助金额:
    $ 16.14万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了